| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3848924 | American Journal of Kidney Diseases | 2012 | 6 Pages |
Abstract
Gentamicin 320 μg/mL in 4% sodium citrate used as a routine catheter lock in CVCs in patients on maintenance hemodialysis therapy markedly decreases the incidence of catheter-related bloodstream infection and is as effective as heparin 1,000 U/mL in preventing catheter clotting.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
John MB, BS, Sumi MPH, Ishrag BS, Alexander PhD, Sheila BSN, RN, CNN, CCRA, Brigitte MD,